SuperworthArcadia Biosciences shares outstanding RKDA
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 3M
- On a year earlier
- +118.9%
- more shares
Arcadia Biosciences had 3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 118.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.4M | +1% |
| FY2024 | 1.4M | +0% |
| FY2023 | 1.4M | +102% |
| FY2022 | 672.9K | +21% |
| FY2021 | 554.6K | +100% |
| FY2020 | 277.9K | +29% |
| FY2019 | 215.9K | +81% |
| FY2018 | 119.3K | +124% |
| FY2017 | 53.4K | −4% |
| FY2016 | 55.6K | +1% |
| FY2015 | 55.1K | +2031% |
| FY2014 | 2.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 3M | +119% | |
| Q1 FY26 | 2.1M | +52% | |
| Q4 FY25 | 1.4M | +1% | |
| Q3 FY25 | 1.4M | +1% | |
| Q2 FY25 | 1.4M | +0% | |
| Q1 FY25 | 1.4M | +0% | |
| Q4 FY24 | 1.4M | +0% | |
| Q3 FY24 | 1.4M | +0% | |
| Q2 FY24 | 1.4M | +0% | |
| Q1 FY24 | 1.4M | +58% | |
| Q4 FY23 | 1.4M | +102% | |
| Q3 FY23 | 1.4M | +121% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Arcadia Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.